Monday, December 23, 2024
HomeTagsOral Presentation

Oral Presentation

BioMarin Announces Oral Presentation of 2-Year Analysis of Largest Phase 3 Gene Therapy Study in Adults

BioMarin Pharmaceutical Inc. announced that the Company presented positive results from a two-year analysis of the Phase 3 GENEr8-1 study and an overall safety...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics